Literature DB >> 19420196

Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise.

Gerard J Criner1, Patricia Belt2, Alice L Sternberg2, Zab Mosenifar3, Barry J Make4, James P Utz5, Frank Sciurba6.   

Abstract

BACKGROUND: The National Emphysema Treatment Trial studied lung volume reduction surgery (LVRS) for its effects on gas exchange, breathing pattern, and dyspnea during exercise in severe emphysema.
METHODS: Exercise testing was performed at baseline, and 6, 12, and 24 months. Minute ventilation (Ve), tidal volume (Vt), carbon dioxide output (Vco(2)), dyspnea rating, and workload were recorded at rest, 3 min of unloaded pedaling, and maximum exercise. Pao(2), Paco(2), pH, fraction of expired carbon dioxide, and bicarbonate were also collected in some subjects at these time points and each minute of testing. There were 1,218 patients enrolled in the study (mean [+/- SD] age, 66.6 +/- 6.1 years; mean, 61%; mean FEV(1), 0.77 +/- 0.24 L), with 238 patients participating in this substudy (mean age, 66.1 +/- 6.8 years; mean, 67%; mean FEV(1), 0.78 +/- 0.25 L).
RESULTS: At 6 months, LVRS patients had higher maximum Ve (32.8 vs 29.6 L/min, respectively; p = 0.001), Vco(2), (0.923 vs 0.820 L/min, respectively; p = 0.0003), Vt (1.18 vs 1.07 L, respectively; p = 0.001), heart rate (124 vs 121 beats/min, respectively; p = 0.02), and workload (49.3 vs 45.1 W, respectively; p = 0.04), but less breathlessness (as measured by Borg dyspnea scale score) [4.4 vs 5.2, respectively; p = 0.0001] and exercise ventilatory limitation (49.5% vs 71.9%, respectively; p = 0.001) than medical patients. LVRS patients with upper-lobe emphysema showed a downward shift in Paco(2) vs Vco(2) (p = 0.001). During exercise, LVRS patients breathed slower and deeper at 6 months (p = 0.01) and 12 months (p = 0.006), with reduced dead space at 6 months (p = 0.007) and 24 months (p = 0.006). Twelve months after patients underwent LVRS, dyspnea was less in patients with upper-lobe emphysema (p = 0.001) and non-upper-lobe emphysema (p = 0.007).
CONCLUSION: During exercise following LVRS, patients with severe emphysema improve carbon dioxide elimination and dead space, breathe slower and deeper, and report less dyspnea.

Entities:  

Mesh:

Year:  2009        PMID: 19420196      PMCID: PMC2818416          DOI: 10.1378/chest.08-1625

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  36 in total

1.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

2.  Psychophysical scaling with applications in physical work and the perception of exertion.

Authors:  G Borg
Journal:  Scand J Work Environ Health       Date:  1990       Impact factor: 5.024

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

5.  Reference spirometric values using techniques and equipment that meet ATS recommendations.

Authors:  R O Crapo; A H Morris; R M Gardner
Journal:  Am Rev Respir Dis       Date:  1981-06

6.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

7.  Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations.

Authors:  D E O'Donnell; K A Webb
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

8.  Lung volumes in healthy nonsmoking adults.

Authors:  R O Crapo; A H Morris; P D Clayton; C R Nixon
Journal:  Bull Eur Physiopathol Respir       Date:  1982 May-Jun

9.  Standardized single breath normal values for carbon monoxide diffusing capacity.

Authors:  R O Crapo; A H Morris
Journal:  Am Rev Respir Dis       Date:  1981-02

10.  Regional chest wall volumes during exercise in chronic obstructive pulmonary disease.

Authors:  A Aliverti; N Stevenson; R L Dellacà; A Lo Mauro; A Pedotti; P M A Calverley
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

View more
  12 in total

Review 1.  Lung volume reduction surgery or bronchoscopic lung volume reduction: is there an algorithm for allocation?

Authors:  Matthew Gordon; Sean Duffy; Gerard J Criner
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency.

Authors:  Victor Kim; Dana M Kretschman; Alice L Sternberg; Malcolm M DeCamp; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

Review 3.  Lung volume reduction surgery for diffuse emphysema.

Authors:  Joseph Em van Agteren; Kristin V Carson; Leong Ung Tiong; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-10-14

Review 4.  The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery.

Authors:  Gerard J Criner; Francis Cordova; Alice L Sternberg; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2011-10-15       Impact factor: 21.405

5.  Reduced dynamic hyperinflation after LVRS is associated with improved exercise tolerance.

Authors:  Matthew R Lammi; Nathaniel Marchetti; Gerard J Criner
Journal:  Respir Med       Date:  2014-08-06       Impact factor: 3.415

6.  Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.

Authors:  Carolyn E Come; Miguel J Divo; Raúl San José Estépar; Frank C Sciurba; Gerard J Criner; Nathaniel Marchetti; Steven M Scharf; Zab Mosenifar; Barry J Make; Cesar A Keller; Omar A Minai; Fernando J Martinez; MeiLan K Han; John J Reilly; Bartolome R Celli; George R Washko
Journal:  Respir Med       Date:  2011-08-16       Impact factor: 3.415

Review 7.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

8.  Morphologic Response of the Pulmonary Vasculature to Endoscopic Lung Volume Reduction.

Authors:  Farbod N Rahaghi; Carolyn E Come; James Ross; Rola Harmouche; Alejandro A Diaz; Raul San Jose Estepar; George Washko
Journal:  Chronic Obstr Pulm Dis       Date:  2015

Review 9.  Non-pharmacological management of chronic obstructive pulmonary disease.

Authors:  Katherine A Safka; R Andrew McIvor
Journal:  Ulster Med J       Date:  2015-01

Review 10.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.